Inventor · disambiguated record
Scott Wolkenberg
Also filed as: WOLKENBERG SCOTT · WOLKENBERG SCOTT E
18 granted patents·6 pending applications·24 citations·filing 2005–2020
89Inventor score
Files withMERCK SHARP & DOHME7BARROW JAMES C3MERCK & CO INC3WOLKENBERG SCOTT3MERCK SHARP & DOHME LLC2
Top patents by PatentIndex Score
24 records- 0187US7947714B2Piperidine glycine transporter inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted May 24, 2011·7 cites·13 claims
- 0281US7825135B2Heteroaryl piperidine glycine transporter inhibitorsMERCK SHARP & DOHME·Filed 2005·Granted Nov 2, 2010·6 cites·13 claims
- 0377US7776886B2Cyclopropyl piperidine glycine transporter inhibitorsMERCK SHARP & DOHME·Filed 2005·Granted Aug 17, 2010·3 cites·13 claims
- 0476US8530483B2Substituted azabenzoxazolesBARROW JAMES C·Filed 2009·Granted Sep 10, 2013·4 cites·13 claims
- 0570US9624208B2Benzoxazolinone compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2013·Granted Apr 18, 2017·1 cites·5 claims
- 0665US9024032B2Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disordersWOLKENBERG SCOTT·Filed 2011·Granted May 5, 2015·1 cites·86 claims
- 0764US9309199B2Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disordersWOLKENBERG SCOTT·Filed 2011·Granted Apr 12, 2016·1 cites·16 claims
- 0862US9273040B2Benzoxazolinone compounds with selective activity in voltage-gated sodium channelsLAYTON MARK E·Filed 2012·Granted Mar 1, 2016·1 cites·22 claims
- 0953US12281109B2Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetesMERCK SHARP & DOHME LLC·Filed 2020·Granted Apr 22, 2025·0 cites·13 claims
- 1051US12365674B2Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infectionMERCK SHARP & DOHME LLC·Filed 2020·Granted Jul 22, 2025·0 cites·9 claims
- 1150US2011076230A1Novel Substituted IndolesBARROW JAMES C·Filed 2009·Application pending·0 cites
- 1248US2011081297A1Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-OxadiazolesBARROW JAMES C·Filed 2009·Application pending·0 cites
- 1347US2010222322A1Non-Nucleoside Reverse Transcriptase InhibitorsMERCK & CO INC·Filed 2006·Application pending·0 cites
- 1447US2010168097A1Non-Nucleoside Reverse Transcriptase InhibitorsWOLKENBERG SCOTT E·Filed 2006·Application pending·0 cites
- 1546US7576083B2Morpholinyl piperidine glycine transporter inhibitorsMERCK & CO INC·Filed 2005·Granted Aug 18, 2009·0 cites·21 claims
- 1646US2009258853A1Somatostatin AgonistsEASTMAN BRIAN·Filed 2007·Application pending·0 cites
- 1745US9260413B2Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disordersMERCK SHARP & DOHME·Filed 2014·Granted Feb 16, 2016·0 cites·18 claims
- 1844US7973059B2Potassium channel inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted Jul 5, 2011·0 cites·11 claims
- 1942US7572792B2Azetidine glycine transporter inhibitorsMERCK & CO INC·Filed 2005·Granted Aug 11, 2009·0 cites·24 claims
- 2041US8148535B2Potassium channel inhibitorsTROTTER B WESLEY·Filed 2006·Granted Apr 3, 2012·0 cites·8 claims
- 2141US2010179122A1Non-Nucleoside Reverse Transcriptase InhibitorsLINDSLEY CRAIG W·Filed 2006·Application pending·0 cites
- 2240US9399651B2Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disordersMERCK SHARP & DOHME·Filed 2015·Granted Jul 26, 2016·0 cites·41 claims
- 2340US8278317B2Potassium channel inhibitorsTROTTER B WESLEY·Filed 2006·Granted Oct 2, 2012·0 cites·4 claims
- 2435US8969364B2Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disordersWOLKENBERG SCOTT·Filed 2011·Granted Mar 3, 2015·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →